Free Trial

Rocket Pharmaceuticals (RCKTW) SEC Filings & 10K Form

Rocket Pharmaceuticals logo
$0.05 -0.01 (-15.33%)
As of 05/2/2025 03:59 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Rocket Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/30/2025
3:14 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEF 14A
04/30/2025
3:15 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form DEFA14A
04/30/2025
3:16 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form ARS
04/22/2025
2:17 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/14/2025
5:57 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/14/2025
4:10 PM
MAVERICK CAPITAL LTD (Filed by)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form SCHEDULE 13G
04/10/2025
3:07 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
2:26 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/08/2025
3:06 PM
Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
4:24 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
2:25 PM
Ondrey Aaron (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
3:01 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Schwartz Jonathan David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:01 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
11:56 AM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Schwartz Jonathan David (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:29 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:09 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2025
3:11 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/10/2025
9:25 AM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
02/05/2025
6:47 PM
Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:43 PM
Pratumsuwan Piratip (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2025
2:15 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/27/2025
8:28 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
2:33 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
6:38 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
RTW INVESTMENTS, LP (Reporting)
WONG RODERICK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
6:51 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13D/A
12/12/2024
5:02 AM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 424B5
11/25/2024
3:05 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
3:05 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:26 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
3:06 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:58 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/21/2024
2:27 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
3:15 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
9:52 AM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
3:45 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
2:24 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
2:34 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
4:05 PM
Bjork Elisabeth (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
09/11/2024
3:07 PM
Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:05 PM
Dolsten Mikael (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2024
3:06 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2024
3:26 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
2:29 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:39 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:16 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/16/2024
2:23 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2024
3:15 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:05 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
2:22 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:05 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
White Mark Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
2:17 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
White Mark Andrew (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
9:34 AM
Makker Gotham (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4/A
05/20/2024
3:33 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Shah Gaurav (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:36 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:39 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
SOUTHWELL DAVID P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:26 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:29 PM
ROCKET PHARMACEUTICALS, INC. (Issuer)
Rocket Pharmaceuticals (Issuer)
Wilson Martin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:27 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Shah Gaurav (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
2:41 PM
Militello John (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
2:41 PM
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Wilson Martin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/16/2024
2:44 PM
Patel Kinnari (Reporting)
ROCKET PHARMACEUTICALS, INC. (Subject)
Rocket Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
3:05 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
4:26 PM
ROCKET PHARMACEUTICALS, INC. (Filer)
Rocket Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RCKTW) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners